Cipla PE Ratio
PE ratio as of May 2025 (TTM) : 23.88 | Industry PE : 45.08
Last Updated Date: 15th May, 2025Cipla PE ratio analysis
- PE Ratio of Cipla has increased by 12.88% compared to the previous Financial Year.
- PE Ratio with value of 32.64 was highest in Year 2022 in the last 5 years.
- PE Ratio with value of 22.04 was lowest in Year 2020 in the last 5 years.
- Latest PE Ratio with value of 29.28 is higher than the Average PE of 27.45 in the last 5 years.
Historical P/E Ratio of Cipla
Cipla PE ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2024 | 29.28 | +12.88% |
| 2023 | 25.94 | -20.53% |
| 2022 | 32.64 | +19.39% |
| 2021 | 27.34 | +24.05% |
| 2020 | 22.04 | -- |
PE Ratio Comparison with Peers of Cipla
| Peers & Returns | Market Capitalization | PE Ratio |
|---|---|---|
| Laurus Labs | 33,463.31 Cr | 92.30 |
| Suven Pharmaceuticals | 28,910.94 Cr | 57.34 |
| Divi's Laboratories | 1,62,042.02 Cr | 57.02 |
| Torrent Pharmaceuticals | 1,10,170.76 Cr | 53.15 |
| Mankind Pharma | 98,432.98 Cr | 48.11 |
| Ipca Laboratories | 34,965.52 Cr | 47.96 |
Disclaimer: The figures and information provided are for informational purposes only and may vary over time. The above data may be outdated and not reflect the latest updates. Always conduct thorough research and consult a financial advisor before making any investment decisions.
Quick Links for Cipla
Cipla Balance Sheet | Cipla Quarterly Result | Cipla Stock Split History | Cipla AGM / EGM | Cipla Rights | Cipla Board Meeting | Cipla EPS | Cipla Bonus | Cipla ROE Ratio | Cipla Shareholding | Cipla Bulk and Block Deals | Cipla Insider Trading and SAST | Cipla PE | Cipla PB | Cipla Income statement | Cipla Cashflow
Other Price to Earning Pages
Data Source - Dion Global Solutions Limited